| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.908310 |
| 003 | CaOODSP |
| 005 | 20221107181627 |
| 006 | m o d f |
| 007 | cr cn||||||||| |
| 008 | 220221t20162016onc o f000 0 eng d |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aH164-328/2016E-PDF |
| 245 | 00|aGuidance document : |bNotice of Compliance with conditions (NOC/c). |
| 246 | 30|aNotice of Compliance with conditions (NOC/c) |
| 264 | 1|aOttawa, ON : |bHealth Canada, Health Products and Food Branch, |c[2016] |
| 264 | 4|c©2016 |
| 300 | |a1 online resource (iii, 50 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCover title. |
| 500 | |a"Date adopted : 2002/11/06; revised date : 2016/09/16; effective date : 2016/09/16." |
| 500 | |aIssued also in French under title: Ligne directrice : Avis de conformité avec conditions (AC-C). |
| 500 | |a"This guidance document combines and supercedes the policy and guidance documents for Notices of Compliance with Conditions (NOC/c) dated June 12, 2007" -- page 1. |
| 650 | 0|aDrugs|xTesting|xGovernment policy|zCanada. |
| 650 | 0|aDrugs|xCertification|zCanada. |
| 710 | 1 |aCanada. |bHealth Products and Food Branch, |eissuing body. |
| 775 | 08|tLigne directrice : |w(CaOODSP)9.908309 |
| 856 | 40|qPDF|s446 KB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H164-328-2016-eng.pdf |